Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3
The primary objective of the study was to evaluate whether progression-free...
Status
Terminated
Location
University of Alabama at Birmingham - Main /ID# 138087
Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer
PHASE1
The study seeks to assess the efficacy of veliparib (ABT-888) in combinatio...
Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
PHASE1
This study seeks to establish the recommended Phase 2 dose (RPTD) of velipa...
Status
Completed
Location
University of Alabama at Birmingham - Main /ID# 155135
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)
PHASE1
This study seeks to establish
* the recommended Phase 2 dose (RPTD) of vel...
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers
PHASE3
The purpose of this study is to evaluate the safety and efficacy of velipar...
Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer
PHASE2
The primary objective of this study is to evaluate the efficacy and safety ...
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
PHASE3
The primary objective of the study is to assess the progression-free surviv...